Posts
-
News and Updates,
Cystetic Medicines Doses First Person with Cystic Fibrosis in Phase 1 Trial of Investigational Therapy CM001, Designed to Form Ion Channels to Help Restore Airway Function
-
News and Updates,
cystetic Medicines Initiates Phase 1 Clinical Trial of a Molecular Prosthetic for Cystic Fibrosis
-
Scientific Publications,
A dry powder aerosol comprising a small molecule prosthetic ion-channel for treatment of people with cystic fibrosis
-
Scientific Publications,
A rationally designed molecular prosthetic for cystic fibrosis
-
News and Updates,
Antifungal drug improves key cystic fibrosis biomarkers in clinical study
-
News and Updates,
Two UIs work together on cystic fibrosis breakthrough
-
News and Updates,
Company co-founded by Carle Illinois faculty member secures $25 million to advance promising new cystic fibrosis treatment